--- title: "BLS Capital Q1 2026: $2.9B Danish Quality Compounder Book" type: research slug: bls-capital-q1-2026-danish-quality-compounder-yum-china canonical_url: https://13finsight.com/research/bls-capital-q1-2026-danish-quality-compounder-yum-china published_at: 2026-05-15T07:48:04.560Z updated_at: 2026-05-15T07:48:10.305Z author: Marcus Chen author_title: Senior Market Analyst author_url: https://13finsight.com/authors/marcus-chen word_count: 737 locale: en source: 13F Insight --- # BLS Capital Q1 2026: $2.9B Danish Quality Compounder Book > BLS Capital Fondsmaeglerselskab — Denmark's largest independent equity manager — files a $2.94 billion Q1 2026 13F dominated by global quality compounders. Yum China (YUMC) at 18.88% portfolio, S&P Global at 12.75%, Otis at 11.51%, AutoZone at 10.08%. The Scandinavian quality-discipline book at scale. BLS Capital Fondsmaeglerselskab A/S is one of Denmark's larger independent equity-investment firms. The firm runs concentrated global-equity strategies with explicit value-and-quality factor tilts and a stated preference for durable-moat compounders. The Q1 2026 Form 13F-HR reports $2.94 billion in US-listed equity holdings concentrated in 10 dominant positions: Yum China (YUMC) at 18.88% portfolio, S&P Global (SPGI) at 12.75%, Otis Worldwide (OTIS) at 11.51%, AutoZone (AZO) at 10.08%, Automatic Data Processing (ADP) at 8.15%, Zoetis (ZTS) at 7.87%, Moody's (MCO) at 7.70%, Mastercard (MA) at 7.63%, Visa (V) at 6.07%, Arthur J. Gallagher (AJG) at 4.77%. Top 10 concentration: 95.41% of AUM. The book is structurally a Scandinavian quality-compounder expression at scale.BLS Capital's mandate emphasizes companies with durable competitive moats, high-margin operating economics, recurring-revenue characteristics, capital-light growth, and management capital-allocation discipline. The 13F shape reflects systematic application of these criteria across global equity universe — note that several positions are non-US-domiciled companies (YUMC is China-focused; OTIS is global elevator-and-escalator).The book at a glance$2.94 billion total AUM. ~10-20 meaningful positions. WhaleScore 79.00. Top 10 concentration: 95.41% — essentially the entire book.The top 10 in detailYum China (YUMC) at 18.88% — KFC, Pizza Hut, Taco Bell China operator. The Chinese quick-service-restaurant franchise. BLS Capital's largest position.S&P Global (SPGI) at 12.75% — Credit ratings, market intelligence, indices. Two-sided network economics, regulatory-protected pricing power.Otis Worldwide (OTIS) at 11.51% — Elevators and escalators globally. Service-revenue compounder (60%+ of revenue from maintenance contracts).AutoZone (AZO) at 10.08% — Aftermarket auto parts retail. Buyback machine plus pricing power on parts replacement.Automatic Data Processing (ADP) at 8.15% — Payroll and HR services. Recurring-revenue platform with regulatory moat.Zoetis (ZTS) at 7.87% — Animal health pharmaceuticals. Premium pricing on companion-animal and livestock products.Moody's (MCO) at 7.70% — Credit ratings duopoly with S&P.Mastercard (MA) at 7.63% — Payments network.Visa (V) at 6.07% — Payments network.Arthur J. Gallagher (AJG) at 4.77% — Insurance brokerage. M&A-driven compounder with capital-light economics.Combined Mastercard + Visa + S&P Global + Moody's exposure: 34.15% of portfolio in financial-services data and payments infrastructure. The cluster reflects BLS Capital's view that information-and-transaction infrastructure provides durable compounding economics.What's deliberately absentThe exclusions are striking:Zero Magnificent 7 mega-cap tech. NVDA, AAPL, MSFT, AMZN, GOOGL, META, TSLA — all absent. The Magnificent 7 fails BLS Capital's value-and-quality screens at current multiples.Zero energy or commodity positions. XOM, CVX, COP, COG, etc. — absent.Zero pharma or biotech. JNJ, LLY, PFE, MRK — absent. Animal-health Zoetis is the closest sector exposure.Zero defense or industrial heavy machinery beyond Otis. No CAT, DE, LMT, RTX.BLS Capital's book is structurally a quality-compounder concentration — financial-and-information services platforms plus consumer-services compounders plus selective industrial services exposure. The non-participation in the major US sectors (mega-cap tech, energy, healthcare pharma, defense) is a deliberate philosophical choice.The top 10 vs the rest95.41% of AUM in 10 positions. The remaining 4.59% spans a handful of smaller positions. The structure is concentrated-active by design — BLS Capital does not run diversified equity allocations beyond its high-conviction selections.What this 13F tells institutional readersQuality-compounder concentration is the thesis. Every top-10 position fits the durable-moat, high-margin, capital-light, recurring-revenue framework. The structural pattern is explicit factor expression.YUMC at 18.88% is the China-specific bet. Yum China is the largest exposure to Chinese consumer-discretionary spending at this concentration. The position represents BLS Capital's view that Chinese QSR franchise growth continues despite broader China-equity multiple compression.The non-participation in mega-cap tech is deliberate. BLS Capital screens out names trading at multiples too high for quality-and-value factor frameworks. The Magnificent 7 absence is philosophical, not accidental.AUM trajectoryBLS Capital's reported US 13F AUM has scaled through 2024-2026 as the firm's global-equity strategies attracted European institutional inflows. The 10-position concentration has been stable; BLS is not letting AUM growth force position-count drift.What to trackYum China Q1 2026 earnings. Chinese consumer-discretionary trajectory and KFC/Pizza Hut China unit-growth determine the largest BLS position outcome.BLS Capital's Q2 2026 13F (due August 14, 2026). Watch whether top-10 positions hold or shift. Track via the institutional signals feed.Payments-network regulation. Combined V + MA + SPGI + MCO at 34.15% portfolio means any Credit Card Competition Act passage or credit-ratings regulation directly affects the book.BLS Capital's Q1 2026 13F is one of the cleanest Scandinavian quality-compounder concentrated books at scale in the US 13F universe. For more on identifying quality-discipline 13F shapes, see our payments duopoly decoder.Source: SEC Form 13F-HR filed by BLS Capital Fondsmaeglerselskab A/S (CIK 0001670104) for the period ending 2026-03-31; available via EDGAR — BLS Capital filer index. ## FAQ ### What is BLS Capital Fondsmaeglerselskab? BLS Capital Fondsmaeglerselskab A/S is one of Denmark's larger independent equity-investment firms. The firm runs concentrated global-equity strategies with explicit value-and-quality factor tilts and a stated preference for durable-moat compounders. WhaleScore 79.00 places BLS Capital in the elite smart-money tier. Q1 2026 13F reports $2.94 billion in US-listed equity holdings across ~10 meaningful positions. ### Why is Yum China BLS Capital's largest position? Yum China (YUMC) at 18.88% portfolio represents BLS Capital's largest single-name bet on the Chinese quick-service-restaurant franchise (KFC, Pizza Hut, Taco Bell China). The thesis combines QSR unit-growth in China, the cash-flow-compounder economics of franchise restaurants, and the multi-year operational platform of Yum China's spun-off independence (Yum Brands separated Yum China in 2016). BLS Capital views this as one of the highest-quality Chinese consumer-discretionary expressions. ### Why are mega-cap tech names absent from BLS Capital? BLS Capital's quality-and-value factor screens filter out names trading at multiples too high for the firm's framework. NVDA, AAPL, MSFT, AMZN, GOOGL, META, TSLA are all absent. The Magnificent 7 fails the firm's value-discipline threshold at current multiples. The exclusion is philosophical — BLS Capital prefers tax-and-toll information-services platforms (Mastercard, Visa, Moody's, S&P Global) and consumer-services compounders (Otis, AutoZone, ADP) over high-multiple growth. ### How concentrated is BLS Capital's book? Top 10 absorbs 95.41% of total AUM. The remaining 4.59% spans a handful of smaller positions. This is meaningfully more concentrated than US-active managers at comparable AUM (Clearbridge Investments runs 25.4% top-10 at $114B AUM; MFS runs 20.6% at $297B). BLS Capital's concentration reflects the Scandinavian institutional-mandate preference for high-conviction quality-discipline holdings rather than broad index-aware diversification. --- Source: 13F Insight — https://13finsight.com/research/bls-capital-q1-2026-danish-quality-compounder-yum-china Author: Marcus Chen — https://13finsight.com/authors/marcus-chen Last updated: 2026-05-15T07:48:10.305Z